Command Palette

Search for a command to run...

Clinical Trials · NCT01654120

Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics

CompletedPhase 4Liraglutide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
Mountain Diabetes and Endocrine Center
Enrollment
37
Start date
Dec 2011
Locations
1 site, United States
Primary endpoint
Change from baseline in HbA1c at six months
View Liraglutide compound reference